glycerol has been researched along with Nervous System Diseases in 26 studies
Moon: The natural satellite of the planet Earth. It includes the lunar cycles or phases, the lunar month, lunar landscapes, geography, and soil.
Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The results in 122 patients with trigeminal neuralgia who underwent percutaneous retrogasserian glycerol injection are presented." | 8.78 | Percutaneous retrogasserian glycerol injection in the management of trigeminal neuralgia: long-term follow-up results. ( Fujimaki, T; Fukushima, T; Miyazaki, S, 1990) |
| "Twenty nine patients with trigeminal neuralgia were treated by retrogasserian glycerol injection method." | 7.67 | [Glycerol injection method for trigeminal neuralgia]. ( Igarashi, S; Iwasaki, K; Koyama, T; Suzuki, F; Umeda, S, 1985) |
| "The results in 122 patients with trigeminal neuralgia who underwent percutaneous retrogasserian glycerol injection are presented." | 4.78 | Percutaneous retrogasserian glycerol injection in the management of trigeminal neuralgia: long-term follow-up results. ( Fujimaki, T; Fukushima, T; Miyazaki, S, 1990) |
| "Fourteen of 60 cases (23%) of trigeminal neuralgia underwent a repeat trigeminal cistern glycerol injection for recurrent pain." | 3.67 | Recurrent trigeminal cistern glycerol injections for tic douloureux. ( Gomori, JM; Rappaport, ZH, 1988) |
| "Twenty nine patients with trigeminal neuralgia were treated by retrogasserian glycerol injection method." | 3.67 | [Glycerol injection method for trigeminal neuralgia]. ( Igarashi, S; Iwasaki, K; Koyama, T; Suzuki, F; Umeda, S, 1985) |
| "Neurological and hearing impairment was assessed at discharge and after 1 month." | 2.73 | Role of dexamethasone and oral glycerol in reducing hearing and neurological sequelae in children with bacterial meningitis. ( Bansal, A; Ray, P; Sankar, J; Singhi, P; Singhi, S, 2007) |
| "Primary end points were death, severe neurological sequelae, or deafness, with the first 2 end points forming a composite end point." | 2.73 | Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. ( Arbo, A; Ayala, SG; Bologna, R; de Andrade, SD; Fernández, J; Goyo, J; López, E; Mata, AG; Miño, G; Peltola, H; Roine, I; Sarna, S; Zavala, I, 2007) |
| "Glycerol was the only osmotic therapy evaluated, and data from trials to date have not demonstrated an effect on death." | 2.58 | Osmotic therapies added to antibiotics for acute bacterial meningitis. ( Ajdukiewicz, KM; Bergman, H; Garner, P; Heyderman, RS; Wall, EC, 2018) |
| "Neither of the adjuvants prevented hearing impairment, regardless of agent or timing of antibiotic." | 2.45 | Improving the outcomes in children with bacterial meningitis. ( Peltola, H; Roine, I, 2009) |
| "Glycerol acute renal failure (ARF) was examined to see if it alters theophylline (Th) neurotoxicity in rats." | 1.28 | Theophylline neurotoxicity is unaffected by glycerol-induced renal failure. ( Ramzan, I, 1990) |
| "Glycerol has a non-specific neurotoxic effect which is equal for tactile and nociceptive fibres." | 1.28 | Sensory disturbance following percutaneous retrogasserian glycerol rhizotomy. ( Bergenheim, AT; Brophy, BP; Laitinen, LV, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (34.62) | 18.7374 |
| 1990's | 4 (15.38) | 18.2507 |
| 2000's | 9 (34.62) | 29.6817 |
| 2010's | 4 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wall, EC | 1 |
| Ajdukiewicz, KM | 1 |
| Bergman, H | 1 |
| Heyderman, RS | 1 |
| Garner, P | 1 |
| Haglind, CB | 1 |
| Nordenström, A | 1 |
| Ask, S | 1 |
| von Döbeln, U | 1 |
| Gustafsson, J | 1 |
| Stenlid, MH | 1 |
| Maysinger, D | 1 |
| Gröger, D | 1 |
| Lake, A | 1 |
| Licha, K | 1 |
| Weinhart, M | 1 |
| Chang, PK | 1 |
| Mulvey, R | 1 |
| Haag, R | 1 |
| McKinney, RA | 1 |
| Dohare, P | 1 |
| Zia, MT | 1 |
| Ahmed, E | 1 |
| Ahmed, A | 1 |
| Yadala, V | 1 |
| Schober, AL | 1 |
| Ortega, JA | 1 |
| Kayton, R | 1 |
| Ungvari, Z | 1 |
| Mongin, AA | 1 |
| Ballabh, P | 1 |
| Peltola, H | 3 |
| Roine, I | 2 |
| Sarrafzadeh, A | 1 |
| Haux, D | 1 |
| Sakowitz, O | 1 |
| Benndorf, G | 1 |
| Herzog, H | 1 |
| Kuechler, I | 1 |
| Unterberg, A | 1 |
| POLACEK, L | 1 |
| Illsinger, S | 1 |
| Marquardt, I | 1 |
| Lücke, T | 1 |
| Hellerud, C | 1 |
| Korenke, C | 1 |
| Das, AM | 1 |
| Sankar, J | 1 |
| Singhi, P | 1 |
| Bansal, A | 1 |
| Ray, P | 1 |
| Singhi, S | 1 |
| Fernández, J | 1 |
| Zavala, I | 1 |
| Ayala, SG | 1 |
| Mata, AG | 1 |
| Arbo, A | 1 |
| Bologna, R | 1 |
| Miño, G | 1 |
| Goyo, J | 1 |
| López, E | 1 |
| de Andrade, SD | 1 |
| Sarna, S | 1 |
| Sáez-Llorens, X | 1 |
| McCracken, GH | 1 |
| Kilpi, T | 1 |
| Jauhiainen, T | 1 |
| Kallio, MJ | 1 |
| van Zuylen, L | 1 |
| Verweij, J | 2 |
| Sparreboom, A | 2 |
| Gelderblom, H | 1 |
| Nooter, K | 1 |
| Quest, DO | 1 |
| Kohlschütter, A | 1 |
| Seitz, HJ | 1 |
| Feldmann, B | 1 |
| Lehnert, W | 1 |
| Langenbeck, U | 1 |
| Ramzan, I | 1 |
| Fujimaki, T | 1 |
| Fukushima, T | 1 |
| Miyazaki, S | 1 |
| Rappaport, ZH | 1 |
| Gomori, JM | 1 |
| Laitinen, LV | 1 |
| Brophy, BP | 1 |
| Bergenheim, AT | 1 |
| Caplan, LR | 1 |
| Harry, GJ | 1 |
| Goodrum, JF | 1 |
| Bouldin, TW | 1 |
| Wagner-Recio, M | 1 |
| Toews, AD | 1 |
| Morell, P | 1 |
| Igarashi, S | 1 |
| Suzuki, F | 1 |
| Iwasaki, K | 1 |
| Koyama, T | 1 |
| Umeda, S | 1 |
| Vána, V | 1 |
| Tan, PJ | 1 |
| Xu, M | 1 |
| Sessler, DI | 1 |
| Bashour, CA | 1 |
| LYLE, DJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Non-interventional Study of Nab-paclitaxel (Abraxane®) in Combination With Carboplatin as First Line Therapy in Patients With Advanced Non-small Cell Lung Cancer (NEPTUN)[NCT02799862] | 408 participants (Actual) | Observational | 2016-08-29 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 reviews available for glycerol and Nervous System Diseases
| Article | Year |
|---|---|
Osmotic therapies added to antibiotics for acute bacterial meningitis.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Child; Combined Modality Therapy; | 2018 |
Improving the outcomes in children with bacterial meningitis.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Clinical Trials as Topic; Dexamethasone; Glycerol; H | 2009 |
Role of formulation vehicles in taxane pharmacology.
Topics: Animals; Anthracyclines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; ATP | 2001 |
Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chemistry, Pharmaceu | 2001 |
Percutaneous retrogasserian glycerol injection in the management of trigeminal neuralgia: long-term follow-up results.
Topics: Adult; Aged; Aged, 80 and over; Female; Follow-Up Studies; Glycerol; Humans; Injections; Male; Middl | 1990 |
4 trials available for glycerol and Nervous System Diseases
| Article | Year |
|---|---|
Acute focal neurological deficits in aneurysmal subarachnoid hemorrhage: relation of clinical course, CT findings, and metabolite abnormalities monitored with bedside microdialysis.
Topics: Acute Disease; Biomarkers; Brain; Cerebral Angiography; Demography; Disease Progression; Female; Glu | 2003 |
Role of dexamethasone and oral glycerol in reducing hearing and neurological sequelae in children with bacterial meningitis.
Topics: Acute Disease; Administration, Oral; Child; Child, Preschool; Dexamethasone; Dose-Response Relations | 2007 |
Adjuvant glycerol and/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial.
Topics: Adolescent; Anti-Bacterial Agents; Anti-Inflammatory Agents; Ceftriaxone; Chemotherapy, Adjuvant; Ch | 2007 |
Oral glycerol and intravenous dexamethasone in preventing neurologic and audiologic sequelae of childhood bacterial meningitis. The Finnish Study Group.
Topics: Administration, Oral; Adolescent; Ceftriaxone; Child; Child, Preschool; Confidence Intervals; Dexame | 1995 |
17 other studies available for glycerol and Nervous System Diseases
| Article | Year |
|---|---|
Increased and early lipolysis in children with long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency during fast.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Age Factors; Biomarkers; Blood Glucose; Calorimetry, Indirect; Car | 2015 |
Dendritic Polyglycerol Sulfate Inhibits Microglial Activation and Reduces Hippocampal CA1 Dendritic Spine Morphology Deficits.
Topics: Animals; CA1 Region, Hippocampal; Cell Line; Dendritic Spines; Glycerol; Inflammation; Interleukin-6 | 2015 |
AMPA-Kainate Receptor Inhibition Promotes Neurologic Recovery in Premature Rabbits with Intraventricular Hemorrhage.
Topics: Animals; Animals, Newborn; Apoptosis; Brain; Calcium Signaling; Cerebral Ventricles; Cytokines; Dise | 2016 |
[Use of o-tolyether glycerol in neurology].
Topics: Glycerol; Mephenesin; Nervous System; Nervous System Diseases; Neurology | 1953 |
Two cases of isolated glycerol kinase deficiency with heterogeneous neurological symptoms.
Topics: Child, Preschool; Chromosomes, Human, X; Diet, Fat-Restricted; Glycerol; Glycerol Kinase; Humans; Hy | 2007 |
Glycerol and bacterial meningitis.
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents; Chemotherapy, Adjuvant; Child; Child, Preschool; De | 2007 |
Dehydrating agents commonly used in neurosurgery: advantages and disadvantages.
Topics: Diuretics, Osmotic; Furosemide; Glycerol; Humans; Mannitol; Nervous System Diseases; Postoperative C | 1979 |
Glyceroluria in healthy adults, mentally ill adults and children selected for metabolic screening.
Topics: Adolescent; Adult; Cerebellum; Child; Child, Preschool; Female; Genetic Linkage; Glycerol; Glycerol | 1991 |
Theophylline neurotoxicity is unaffected by glycerol-induced renal failure.
Topics: Acute Kidney Injury; Animals; Glycerol; Male; Nervous System Diseases; Rats; Rats, Inbred Strains; S | 1990 |
Recurrent trigeminal cistern glycerol injections for tic douloureux.
Topics: Drug Administration Schedule; Glycerol; Humans; Injections; Nervous System Diseases; Palliative Care | 1988 |
Sensory disturbance following percutaneous retrogasserian glycerol rhizotomy.
Topics: Adult; Aged; Glycerol; Humans; Middle Aged; Nervous System Diseases; Sensation; Sensory Thresholds; | 1989 |
Preliminary observations on glycerol in spinal cord and root disease.
Topics: Administration, Oral; Adult; Female; Glycerol; Humans; Male; Middle Aged; Nervous System Diseases; S | 1989 |
Tellurium-induced neuropathy: metabolic alterations associated with demyelination and remyelination in rat sciatic nerve.
Topics: Acetates; Animals; Cerebrosides; Cholesterol; Chromatography, Thin Layer; Glycerol; Lipids; Male; Mi | 1989 |
[Glycerol injection method for trigeminal neuralgia].
Topics: Female; Glycerol; Humans; Injections; Male; Middle Aged; Nervous System Diseases; Radiography; Sensa | 1985 |
[Experiences with the administration of glycerin in neurosurgery].
Topics: Glycerol; Humans; Intracranial Pressure; Nervous System Diseases | 1965 |
Operation timing does not affect outcome after coronary artery bypass graft surgery.
Topics: Acute Kidney Injury; Aged; Coronary Artery Bypass; Coronary Vessels; Elective Surgical Procedures; F | 2009 |
Early ocular manifestations in the Laurence-Mood-Biedi syndrome.
Topics: Eye; Head; Humans; Laurence-Moon Syndrome; Moon; Nervous System Diseases | 1947 |